- Home
- ALGS vs TPCS Comparison
ALGS vs TPCS Comparison
Compare ALGS & TPCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | ALGS | TPCS |
|---|---|---|
| Founded | 2018 | 1956 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Metal Fabrications |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 39.9M | 42.5M |
| IPO Year | 2020 | 2008 |
Fundamental Metrics
Financial Performance| Metric | ALGS | TPCS |
|---|---|---|
| Price | $5.71 | $4.01 |
| Analyst Decision | Strong Buy | |
| Analyst Count | 3 | 0 |
| Target Price | ★ $39.33 | N/A |
| AVG Volume (30 Days) | ★ 227.8K | 40.5K |
| Earning Date | 05-05-2026 | 02-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 88.30 | 64.20 |
| EPS | N/A | ★ N/A |
| Revenue | $2,186,000.00 | ★ $34,031,000.00 |
| Revenue This Year | $32.20 | N/A |
| Revenue Next Year | $4.71 | N/A |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 7.72 |
| 52 Week Low | $5.12 | $2.88 |
| 52 Week High | $13.69 | $6.25 |
Technical Indicators
Market Signals| Indicator | ALGS | TPCS |
|---|---|---|
| Relative Strength Index (RSI) | 39.00 | 52.69 |
| Support Level | N/A | $3.67 |
| Resistance Level | $6.76 | $4.71 |
| Average True Range (ATR) | 0.50 | 0.23 |
| MACD | 0.02 | -0.04 |
| Stochastic Oscillator | 5.56 | 24.20 |
Price Performance
Historical ComparisonAbout ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical-stage biotechnology company focused on developing therapeutics for liver diseases and viral infections. Its pipeline includes drug candidates targeting chronic hepatitis B virus (HBV) infection, metabolic dysfunction-associated steatohepatitis (MASH), obesity, and coronavirus infections, with programs such as pefivfoscorvir sodium for HBV, ALG-055009 for MASH and obesity, and ALG-097558 for coronavirus infections.
About TPCS TechPrecision Corporation
Techprecision Corp manufactures metal fabricated and machined precision components and systems. It offers a full range of services required to transform raw materials into precision finished products. The company's products are used in markets including defense, aerospace, nuclear, medical, and precision industries. All of its operations and customers are located in the United States. The company have two wholly owned subsidiaries that are each reportable segments: Ranor and Stadco. Each reportable segment focuses on the manufacture and assembly of specific components. It derives maximum revenue from Ranor segment.